# Paolo De Nadai

> Paolo De Nadai is a pre-seed investor at WeRoad backing AgTech and Cannabis. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: WeRoad
- Location: Milan, Italy
- Total investments: 2
- Last investment: Mar 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/paolodenadai/
- Facebook: https://www.facebook.com/paolo.denadai

Paolo De Nadai is a pre-seed investor at WeRoad in Milan focused on AgTech and Cannabis. Entrepreneur, Paolo launched his first company in 2007 when he was only 19 years old. What was only a blog for local students in Padua, his native cty, it is today the largest online community of students in Italy, with more than 3,8 million followers on social network, one online newspapers and many CSR projects to break the walls among publicinstitutions and the students. ScuolaZoo is the one and only best classmate and student rapresentative of all the high school Italian students in Italy. In 2012 the strenght of the online community was so strong that the fans and followers themselves asked for a "physical" appointment to meet each other: for this reason Paolo founded a new start up: Travel4Target, that designs and sells students breaks for more than 15,000 high school and university students in Italy each year. Brands and corporates soon found out the potential of the media and the student breaks to meet the student target and become relevant for it. For this reason Paolo founded ZooCom, a creative media agency, in 2014. In 2017 Paolo, along with Fabio Bin and Erika De Santi, decided to launch a new way to travel and to build community around the Millennials: it was the year of the launch of WeRoad that today employs more than 60 members and has a community of more than 300 coordinators for its 150 weeks of trips and 5,000 participants to the trips each year. In total, Paolo launched 6 start up with a total revenue of €15 million.

## Contacts

5 contacts available for Paolo De Nadai: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/paolo-de-nadai?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| AgTech | 1 | 50% |
| Cannabis | 1 | 50% |
| Health Care | 1 | 50% |
| Manufacturing | 1 | 50% |
| Mental Health | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Pre-Seed | 1 | 50% |
| Convertible Note | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Italy | 1 | 50% |
| United States | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Open Book Extracts | Open Book Extracts is a cGMP certified, vertically integrated grower, processor, and manufacturer of premium plant-based products. With control of the entire supply chain, a state-of-the-art extraction campus near North Carolina’s Research Triangle, proprietary refinement and conversion methods backed by a growing IP portfolio, and a team of Ph.D.chemists and seasoned business leaders, OBX is the trusted partner for global brands seeking to enter the marketplace. OBX Asia, with its headquarters in Hong Kong, provides strategic guidance and on-the-ground support for our Asia customers.OBX’s cGMP-certified productions operations are led by a seasoned science team, including a Ph.D. food scientist from Cornell, a Ph.D. organic chemist from the University of Nevada, and two masters chemists with pharmaceutical backgrounds, including a quality control director who joined OBX after a 15-year career as an analytical chemist at GlaxoSmithKline. OBX offers one of the largest portfolios of cannabinoid isolates at 99%+ purity, including CBD, CBG, CBN, CBC, and THCV, as well as formulation services and turnkey, finished good manufacturing including edibles, soft gels, tablets, tinctures, pet products, and topical products. | $2M | Convertible Note | Mar 26, 2024 |  |
| Serenis Health | Serenis Health provides video-based psychotherapy, coaching, and psychological support courses. It believes that the internet is critical to increasing access to mental health care. It makes use of data and digital tools to improve the efficacy of therapies. But, unlike other platforms, it is also a medical center, which means it is responsible forcourse quality and must meet the same standards as any polyclinic. | $1.3M | Pre-Seed | Nov 18, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [Bending Spoons](https://shizune.co/investors/profile/bending-spoons) — VC Fund, 1 deal together
- [Exor Ventures](https://shizune.co/investors/profile/exor-seeds) — VC Fund, 1 deal together
- [EXOR N.V.](https://shizune.co/investors/profile/exor-s-p-a) — VC Fund, 1 deal together
- [Exor Ventures](https://shizune.co/investors/profile/exor-ventures) — VC Fund, 1 deal together

## About WeRoad

VC Fund · Milan, Italy

Founded in 2017, WeRoad is one of Europe’s fastest-growing adventure travel platforms for Millennial and Gen Z travellers. Mainly operating in the UK, Germany, France, Spain, Italy and the EU region, it connects like-minded people through English-speaking and local-language group adventures in 1,000+ destinations worldwide.With a community of3.5M+ followers on social media, 3,000+ Coordinators and 200K+ travellers served, WeRoad drives strong loyalty, 60% rebook each year and a third of bookings come via word of mouth. Recognised by Interbrand as a next-generation competitive Italian brand and listed by Sifted among Europe’s fastest-growing startups in 2024.

4 contacts available at WeRoad.

| Name | Title | Profile |
| --- | --- | --- |
| Erika De Santi | Co-Founder & Managing Director | — |
| Fabio Bin | Co-founder & CMO | — |
| Paolo De Nadai | Founder & CEO | https://shizune.co/investors/profile/paolo-de-nadai |
| Valerio Citrani | Guru Weroad | — |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

## FAQ

### What does Paolo De Nadai invest in?

Paolo De Nadai invests primarily in AgTech, Cannabis and Health Care startups, most often at Pre-Seed and Convertible Note stage. Most of the 2 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Paolo De Nadai?

Public channels for Paolo De Nadai include LinkedIn and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Paolo De Nadai last invest?

The most recent investment recorded for Paolo De Nadai closed in Mar 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co